期刊文献+

2019—2021年兰州市严重精神障碍患者管理治疗状况分析 被引量:1

Analysis of the Current Status of Management and Treatment of Patients with Severe Mental Disorders in Lanzhou from2019 to 2021
下载PDF
导出
摘要 目的:分析2019—2021年兰州市严重精神障碍患者管理治疗状况,为兰州市制定防治措施及精神卫生政策提供科学依据。方法:提取甘肃省严重精神障碍信息系统中2019—2021年兰州市严重精神障碍患者相关数据,并用Excel 2007进行统计分析。结果:甘肃省精神卫生监测信息系统显示2019—2021年兰州市在册严重精神障碍患者为11 310例、11 914例、12 295例,报告患病率为3.03‰、 3.19‰、 3.42‰,规范管理率为73.48%、 76.16%、 80.21%,患者面访率为72.25%、79.04%、81.53%,患者规律服药率为32.74%、43.76%、52.05%。结论:2019—2021年兰州市严重精神障碍患者报告患病率、规范管理率、患者面访率以及患者规律服药率均有提高,但报告患病率水平和患者规律服药率水平仍低于国家要求。严重精神障碍患者和家属的病耻感是导致报告患病率与规范管理率偏低的主要原因,而精神卫生资源分布的不均衡性导致远郊患者规律服药率偏低。 OBJECTIVE To understand the current situation of management and treatment of patients with severe mental disorders in Lanzhou in recent three years,and to provide scientific basis for the formulation of prevention and treatment measures and mental health policies.METHODS The relevant data of patients with severe mental disorders in Gansu Province severe mental disorders information System were extracted and analyzed statistically by Excel.RESULTS The mental health monitoring information system of Gansu showed that registered severe mental disorders in Lanzhou were 11310 cases(2019),11914 cases(2020)and 12295 cases(2021),respectively,and the three-year reported prevalence showed 3.03‰(2019),3.19‰(2020)and 3.42‰(2021),with an upward trend.The three-year standard management rate showed an increasing trend,which were 73.48%(2019),76.16%(2020)and 80.21%(2021),respectively.Three years of patient interview rate showed an increasing trend,which were 72.25%,79.04%,81.53%.The rate of regular medication in three years showed an increasing trend,which were 32.74%,43.76%and 52.05%,respectively,except for the standard management rate and interview rate,other indicators were lower than the national requirements.CONCLUSION In the past three years,the management ability of patients with severe mental disorders in Lanzhou showed an upward trend,but the reported prevalence rate and the regular medication rate of patients were still some distance from the national requirements.The stigma of patients with severe mental disorders and their families is the main reason for the low reported prevalence and standardized management rate,and the uneven distribution of mental health resources leads to the low regular medication rate of patients in the outer suburbs.
作者 牛乐宇 Niu Leyu(Lanzhou Provincial Center for Disease Control and Prevention,Lanzhou,Gansu,730030,China)
出处 《中国初级卫生保健》 2024年第3期74-76,共3页 Chinese Primary Health Care
关键词 严重精神障碍 报告患病率 精神卫生 规范管理 规律服药 severe mental disorders reported prevalence rate mental health standardized management regular medication
  • 相关文献

参考文献8

二级参考文献82

  • 1司天梅,陈旭先.精神分裂症患者使用长效抗精神病药物的现况调查[J].中国神经精神疾病杂志,2007,33(10):620-622. 被引量:9
  • 2CHANDRA IS, KUMAR KL, REDDY MP, et al. Attitudes to-ward medication and reasons for non - compliance in patients withschizophrenia [J]. Indian J Psychol Med, 2014, 36(3) : 294 -298.
  • 3DASSA D, BOYER L, BENOIT M, et al. Factors associated withmedication non - adherence in patients suffering from schizophre-nia: a cross - sectional study in a universal coverage health - caresystem [ J]. Aust N Z J Psychiatry, 2010,44( 10) : 921 -928.
  • 4ETICHA T, TEKLU A, ALI D, et al. Factors associated withmedication adherence among patients with schizophrenia inMekelle, Northern Ethiopia [ J]. PLoS One, 2015,10(3):el20560.
  • 5BRESSINGTON D, MUI J, GRAY R. Factors associated with an-tipsychotic medication adherence in community - based patientswith schizophrenia in Hong Kong: a cross sectional study [ J]. IntJ Ment Health Nurs, 2013, 22(1): 35-46.
  • 6SENDT KV, TRACY DK, BHATTACHARYYA S. A systematicreview of factors influencing adherence to antipsychotic medicationin schizophrenia - spectrum disorders [ J]. Psychiatry Res, 2015,225(1 -2): 14-30.
  • 7LI Q, XIANG YT, SU YA, et al. Clozapine in schizophrenia andits association with treatment satisfaction and quality of life ? Find-ings of the three national surveys on use of psychotropic medica-tions in China (2002 - 2012) [ J]. Schizophr Res,2015,168(1-2) : 523 -529.
  • 8CRAMER J A, HOY A, BURRELL A, et al. Medication compli-ance and persistence: terminology and definitions [ J ]. ValueHealth, 2008, 11(1): 44 - 47.
  • 9ANSARI S, MULLA S. Analysis of variables affecting drug com-pliance in schizophrenia [ J]. Ind Psychiatry J,2014, 23 (1) : 58-60.
  • 10MORRISON P,MEEHAN T, STOMSKI NJ. Living with antipsy-chotic medication side - effects : the experience of Australian men-tal health consumers [ J]. Int J Ment Health Nurs, 2015,24(3):253 -261.

共引文献120

同被引文献15

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部